Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 411 of 1,261
  1. US 10716798

    Compositions and methods for tranquilizing heart muscle

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted
  2. US 10716758

    Liposomal statin formulation

    Northwestern University · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted
  3. US 10716782

    LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

    Biomed Valley Discoveries, Inc. · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted
  4. US 10718778

    Compositions and methods for detecting protein sulfenylation

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted
  5. US 10716793

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted
  6. US 10716770

    Nicotinic receptor non-competitive antagonists

    Catalyst Biosciences, Inc. · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted
  7. US 10717799

    Copolymers as excipients for effective solubilization of poorly water-soluble substances from solid mixtures

    Regents of the University of Minnesota · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted
  8. US 10716809

    Methods of producing enriched populations of tumor reactive T cells from peripheral blood

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted
  9. US 10716869

    Radiolabeled macrocyclic EGFR inhibitor

    Oncodesign SA · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted
  10. US 10716789

    Co-crystals and pharmaceutical compositions comprising the same

    Vertex Pharmaceuticals Incorporated · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted
  11. US 10711314

    Methods for diagnosing IDH-mutant cell proliferation disorders

    Agios Pharmaceuticals, Inc. · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted
  12. US 10709758

    Peptide inhibitors of clostridium difficile toxin B (TcdB) toxin

    The Board of Regents of the University of Oklahoma · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted
  13. US 10711028

    Antimicrobial compounds, compositions, and uses thereof

    Lakewood Amedex, Inc. · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted
  14. US 10711029

    Beta-d-2′-deoxy-2′-alpha-fluoro-2′-beta-c-substituted-4′fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection

    Atea Pharmaceuticals, Inc. · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted
  15. US 10709812

    Biodegradable hydrogel for tissue expansion

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted
  16. US 10711068

    Anti-CD133 monoclonal antibodies and related compositions and methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted
  17. US 10711312

    Methods for immunotherapy-based treatment and assessment of cancer

    The Regents of the University of California · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted
  18. US 10711292

    Method for promoting the synthesis of collagen and proteoglycan in chondrocytes

    The Regents of the University of California · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted
  19. US 10711032

    Steroids and protein-conjugates thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted
  20. US 10711007

    Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted
  21. US 10709813

    Solubilization of antigen components for removal from tissues

    The Regents of the University of California · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted
  22. US 10710989

    Method for producing heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted
  23. US 10710983

    2,4-diamino-pyrimidine compounds and method for making and using the compounds

    Rigel Pharmaceuticals, Inc. · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted
  24. US 10710958

    Carbamoyl phenylalaninol compounds and uses thereof

    Jazz Pharmaceuticals Ireland Limited · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.